122 related articles for article (PubMed ID: 23913715)
1. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.
Ono K; Takasaki J; Takahashi R; Ikeda T; Yamada M
J Neurosci Res; 2013 Oct; 91(10):1371-81. PubMed ID: 23913715
[TBL] [Abstract][Full Text] [Related]
2. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Ono K; Hirohata M; Yamada M
J Neurosci Res; 2007 May; 85(7):1547-57. PubMed ID: 17387689
[TBL] [Abstract][Full Text] [Related]
3. Cross-seeding effects of amyloid β-protein and α-synuclein.
Ono K; Takahashi R; Ikeda T; Yamada M
J Neurochem; 2012 Sep; 122(5):883-90. PubMed ID: 22734715
[TBL] [Abstract][Full Text] [Related]
4. Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.
Morinaga A; Ono K; Takasaki J; Ikeda T; Hirohata M; Yamada M
Exp Neurol; 2011 Apr; 228(2):298-302. PubMed ID: 21281631
[TBL] [Abstract][Full Text] [Related]
5. In vitro evidence that an aqueous extract of Centella asiatica modulates α-synuclein aggregation dynamics.
Berrocal R; Vasudevaraju P; Indi SS; Sambasiva Rao KR; Rao KS
J Alzheimers Dis; 2014; 39(2):457-65. PubMed ID: 24284367
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
7. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
8. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
[TBL] [Abstract][Full Text] [Related]
9. Familial Parkinson disease mutations influence α-synuclein assembly.
Ono K; Ikeda T; Takasaki J; Yamada M
Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
[TBL] [Abstract][Full Text] [Related]
10. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
Candreva J; Chau E; Rice ME; Kim JR
Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).
Williams TL; Serpell LC; Urbanc B
Biochim Biophys Acta; 2016 Mar; 1864(3):249-259. PubMed ID: 26699836
[TBL] [Abstract][Full Text] [Related]
12. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
[TBL] [Abstract][Full Text] [Related]
13. Effect of melatonin on α-synuclein self-assembly and cytotoxicity.
Ono K; Mochizuki H; Ikeda T; Nihira T; Takasaki J; Teplow DB; Yamada M
Neurobiol Aging; 2012 Sep; 33(9):2172-85. PubMed ID: 22118903
[TBL] [Abstract][Full Text] [Related]
14. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
[TBL] [Abstract][Full Text] [Related]
15. In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-α-peptide architecture.
Richman M; Wilk S; Chemerovski M; Wärmländer SK; Wahlström A; Gräslund A; Rahimipour S
J Am Chem Soc; 2013 Mar; 135(9):3474-84. PubMed ID: 23360549
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Ono K; Yamada M
J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
18. Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro.
Shozawa H; Oguchi T; Tsuji M; Yano S; Kiuchi Y; Ono K
Neurosci Lett; 2018 Jun; 677():19-25. PubMed ID: 29684530
[TBL] [Abstract][Full Text] [Related]
19. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
20. Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.
Ono K; Yamada M
Neurobiol Dis; 2007 Feb; 25(2):446-54. PubMed ID: 17169566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
